Georgia Power is reminding customers to prioritize safety during spring planting and home improvement projects by calling 811 before digging. This precaution helps prevent power outages, service disruptions, and safety risks by ensuring underground utilities are marked. Additionally, Georgia Power encourages strategic tree planting to improve energy efficiency and avoid future maintenance issues with power lines.

Dollar General is expanding its in-store audio network by partnering with Qsic to deploy an AI-enabled audio network across approximately 6,000 stores, doubling its existing presence. This initiative, part of the DG Media Network, aims to deliver localized, data-driven audio content and targeted ads to customers and brand partners. The retailer is also leveraging other collaborations with Fetch, Kevel, Recess, and Criteo to enhance its retail media capabilities and provide advanced measurement to advertisers.

Regeneron Pharmaceuticals and Telix Pharmaceuticals Ltd. have announced a strategic collaboration to jointly develop and commercialize next-generation radiopharmaceutical therapies. This partnership will combine Regeneron's biologics expertise, including bispecific antibody discovery, with Telix's radiopharmaceutical development platform and manufacturing capabilities. The collaboration aims to address solid tumor targets and develop radio-diagnostics, with Telix receiving an upfront payment of $40 million for initial programs and potential milestones and royalties.

Autodesk (ADSK) stock was downgraded by Citi analyst Tyler Radke from Buy to Neutral, with the price target cut to $246. This downgrade reflects a broader cautious outlook on the software sector rather than specific concerns about Autodesk's fundamentals, though the company faces near-term risks like a sales restructuring and a premium valuation. Despite Citi's bearish stance, the majority of analysts remain bullish on ADSK, with a consensus price target suggesting significant upside.

Energy Transfer LP (ET) is trading at $19.12, showing a generally bullish trend despite a mild 0.36% decline today. The stock is holding above its key moving averages and maintaining bullish technical indicators, with strong buyer domination and low intraday volatility. Experts suggest that ET is expected to consolidate between $19.05 support and $19.60 resistance, with a high probability of an upside move if the $19.05 support holds.

BMO Capital Markets has increased its price target for DuPont de Nemours (NYSE: DD) from $25.10 to $60.00, maintaining an "outperform" rating. This new target represents a potential upside of 27.33% from the previous close, reflecting the company's strong fundamentals and growth potential. Other analysts have also raised their price targets, indicating growing confidence in DuPont's performance within the specialty materials, chemicals, and industrial sectors.

The high-temperature adhesives market, valued at $5.29 billion in 2025, is projected to reach $10.6 billion by 2035 with a CAGR of 7.2%. This growth is driven by industrial development, the adoption of advanced materials, and the increasing need for high-performance bonding solutions in industries like automotive and electronics, particularly in the Asia Pacific region. Key trends include demand for lightweight materials, the expansion of electric vehicles and renewable energy systems, and advancements in adhesive technologies, with major players like 3M, Henkel, and Dow leading innovation.

Citizens Financial Group is experiencing renewed analyst optimism and increasing institutional ownership, with Altfest L J & Co. Inc. significantly boosting its stake in the bank. These developments precede the bank's upcoming earnings report, highlighting growing confidence among professional investors in Citizens' business strategies. Despite this, the article cautions that potential risks from commercial real estate exposure could still impact credit quality and profitability, urging investors to consider various scenarios.

STERIS plc (NYSE: STE), an Irish-domiciled company listed on Nasdaq, is presented as a defensive investment opportunity in the healthcare sector, focusing on infection prevention and sterilization solutions. The company's business model combines hardware sales with recurring service contracts, which account for over half of its revenue, providing stable income and strong margins. STERIS's dominance in a highly regulated market, especially in the US, positions it to benefit from increasing healthcare spending and patient safety priorities, while strategically utilizing bolt-on acquisitions and digital transformation to maintain its competitive edge.

Stryker Corp. is acquiring Amplitude Vascular Systems Inc. (AVS), a medical technology firm specializing in a next-generation intravascular lithotripsy (IVL) platform for calcified peripheral arterial disease. This acquisition will enhance Stryker's Peripheral Vascular portfolio with revascularization technology, complementing its existing offerings and expanding its market presence in arterial disease treatment. The deal aims to provide physicians with expanded treatment options and improve care for patients with calcified peripheral arterial disease.